Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CD39 anticorps (PE)

Cet anticorps Souris Monoclonal détecte spécifiquement CD39 dans FACS. Il présente une réactivité envers Humain.
N° du produit ABIN118627

Aperçu rapide pour CD39 anticorps (PE) (ABIN118627)

Antigène

Voir toutes CD39 (ENTPD1) Anticorps
CD39 (ENTPD1) (Ectonucleoside Triphosphate diphosphohydrolase 1 (ENTPD1))

Reactivité

  • 88
  • 35
  • 25
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 47
  • 44
  • 9
  • 2
  • 1
  • 1
Souris

Clonalité

  • 66
  • 37
  • 1
Monoclonal

Conjugué

  • 51
  • 8
  • 7
  • 6
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CD39 est conjugé à/à la PE

Application

  • 50
  • 38
  • 27
  • 18
  • 15
  • 13
  • 5
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Clone

A1
  • Specificité

    This antibody binds to the Human CD39 cell surface antigen, a 70-100 kDa molecule expressed on peripheral blood B cells, monocytes and T cell clones. CD39 has intrinsic ecto-ATPase activity. Expression is induced on T cells and increased on B cells as a late activation antigen. This antibody has been shown to block MHC independent target cell recognition by hapten-specific CTL. SM1101A is recommended for this purpose (Ref.8).

    Purification

    Affinity Chromatography on Protein G.

    Immunogène

    PHA activated human lymphocytes

    Isotype

    IgG1
  • Indications d'application

    Flow Cytometry: Use 10 μL of neat antibody to label 10^6 cells in 100 μL.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user. Further Comments: This antibody has been shown to block MHC independent target cell recognition by hapten- specific CTL. ABIN118624 is recommended for this purpose (8).

    Restrictions

    For Research Use only
  • Reconstitution

    Restore with 1.0 mL distilled water.

    Concentration

    0.1 mg/mL

    Buffer

    PBS, pH 7.4 containing 0.09 % Sodium Azide as preservative and 1 % BSA as stabilizer.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    This product is photosensitive and should be protected from light

    Stock

    4 °C

    Stockage commentaire

    Prior to and following reconstitution store the antibody undiluted at 2-8 °C. DO NOT FREEZE!
  • Antigène

    CD39 (ENTPD1) (Ectonucleoside Triphosphate diphosphohydrolase 1 (ENTPD1))

    Autre désignation

    CD39 / ENTPD1

    Sujet

    Human CD39 is found on most mature B cells, activated NK cells and activated T cells. CD39 is also weakly expressed on granulocytes. CD39 has homology to the Nmyc family of proteins and was recently cloned. CD39 can hydrolyze both nucleoside triphosphates and diphosphates. CD39 is the dominant ecto nucleotidase of vascular and placental trophoblastic tissues and appears to modulate the functional expression of type 2 purinergic (P2) G protein coupled receptors (GPCRs). CD39 transgenic mice exhibit impaired platelet aggregation, prolonged bleeding times, and resistance to systemic thromboembolism. There is a correlation between ATP hydrolysis and triglycerides in patients with chronic heart disease, suggesting a relationship between ATP diphosphohydrolase and thrombogenesis. Depolarization causes the endothelial production of superoxide, which inhibits the activity of endothelial CD39 and enhances platelet aggregation. After exercise, all subjects showed a significant reduction of CD39 expression in platelet and an increase of CD39 expression in B lymphocytes.Synonyms: ATPDase, Ecto-ATP diphosphohydrolase, Ecto-apyrase, Ectonucleoside triphosphate diphosphohydrolase 1, Lymphoid cell activation antigen, NTPDase 1

    ID gène

    953

    NCBI Accession

    NP_001091645

    UniProt

    P49961
Vous êtes ici:
Chat with us!